As you know, hepatocellular carcinoma is a challenge. Too often patients are diagnosed at an advanced stage; often patients are not referred based on a nihilistic attitude which should belong to the past. Several therapeutic options are available and to select the best for each patient requires expertise.
For the benefit of our patients we plan to organize a HCC Update starting at 14:00 on the 5th December 2019 in Lausanne focusing on hepatocellular carcinoma and bringing together the different specialties.
This event will have CME recognition.
Dr. Nicolas Goossens (Genève Hôspital, CH-Geneve)
Surveillance. The case of NAFLD
PD Dr. Vanessa Banz (Inselspital, CH-Bern)
De novo or salvage Tx
Dr. Alessandro Vitale (Padua University Hospital, Italy)
Tumor Burden and prognosis
Pause
Recipient Price
Dr. Vincent Donckier (Institut Jules Bordet,Brussels, Belgium)
SIRT and resection
Prof. Sandrine Faivre (HUPVNS, Paris, France)
New systemic treatments
Prof. Dufour, Head of Hepatology Department, University Hospital of Berne
Closing remarks
Apéro
